{"id":"W2256341952","doi":"10.1200/jco.2015.63.0970","title":"Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":361,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Fondation Gustave Roussy; Canadian Cancer Society Research Institute; Institut Gustave-Roussy; National Cancer Institute; Institut National Du Cancer; Princess Margaret Cancer Foundation; Sanofi","keywords":"Medicine; Lung cancer; Internal medicine; Hazard ratio; Proportional hazards model; Cisplatin; Oncology; Adjuvant; Chemotherapy; Gastroenterology; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04683284203138601,"score_gpt":0.4285647235886343,"score_spread":0.3817318815572484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}